"April hath put a spirit of youth in everything", Happy April! @TRY3STEPS.COM
Dear Reader, If you use TRY3STEPS a lot, this message is for you. This incredible nonprofit organization helps the world with answers. We love you, we share answers. Your love helps us thrive. The more we give, the more we have! Thank you for inspiring us. (Secure PayPal)

*Everything counts! No minimum transaction limit!
Stay Updated with the World! Subscribe Now:: YouTube.com/c/Try3Steps
Say Hello to Try3Steps Group! Join Now:: GoogleGroup@Try3Steps

Search Another Question

Jan 10, 2022

[Answer] 3. $500. Which one of these drugs is used to treat hyperlipidemia (excessive "bad" cholesterol in the blood)?

Step 1 : Introduction to the question "3. $500. Which one of these drugs is used to treat hyperlipidemia (excessive "bad" cholesterol in the blood)?"



...1. Atorvastatin (Lipitor) 2. Potassium Chloride (Klor-Con) 3. Metformin (Glucophage) 4. Imipramine (Tofranil) Other drugs in atorvastatin's class include simvastatin (Zocor), rosuvastatin (Crestor), and lovastatin (Mevacor). With the official name of HMG-CoA reductase inhibitors, it's easy to see why most people call them "statins." Two other classes of antihyperlipidemics are bile acid sequestrants and fibric acid derivatives.




Step 2 : Answer to the question "3. $500. Which one of these drugs is used to treat hyperlipidemia (excessive "bad" cholesterol in the blood)?"



Atorvastatin (Lipitor):


Please let us know as comment, if the answer is not correct!


Step 3 : Disclaimer & Terms of Use regarding the question "3. $500. Which one of these drugs is used to treat hyperlipidemia (excessive "bad" cholesterol in the blood)?"


Our machine learning tool trying its best to find the relevant answer to your question. Now its your turn, "The more we share The more we have". Share our work with whom you care, along with your comment ...Kindly check our comments section, Sometimes our tool may wrong but not our users.

Are We Wrong To Think We're Right? Then Give Right Answer Below As Comment

No comments:

Post a Comment